199 results on '"Adamiec, R"'
Search Results
2. DNA-dependent RNA polymerase enzymes affected in uraemic lymphocyte cells
- Author
-
Adamiec, R., Szewczyk, Z., and Szopa, J.
- Published
- 1993
- Full Text
- View/download PDF
3. Deoxyribonuclease activity in T and B lymphocytes of haemodialysed patients with uraemia
- Author
-
Adamiec, R., Szewczyk, Z., and Szopa, J.
- Published
- 1992
- Full Text
- View/download PDF
4. Deoxyribonuclease activity in lymphocytes of patients with chronic renal failure treated conservatively
- Author
-
Adamiec, R., Szewczyk, Z., Prochera, J., and Szopa, J.
- Published
- 1991
- Full Text
- View/download PDF
5. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- Author
-
James, Wp, Caterson, Id, Coutinho, W, Finer, N, VAN GAAL LF, Maggioni, Ap, TORP-PEDERSEN, C, Sharma, Am, Shepherd, Gm, Rode, Ra, Renz, Cl, Van Gaal LF, Torp-Pedersen, C, Pepine, C, Pocock, S, Drexler, H, Swedberg, K, Sleight, P, Armstrong, P, Kerr, D, Dagenais, G, Brophy, J, Avezum, A, Bogaty, P, Fabbri, G, Galli, M, Hildebrandt, P, Mann, J, Ostergren, J, Sherman, D, Zannad, F, Colquhoun, D, Hollanders, G, e Forti A, Costa, Cifkova, R, Toubro, S, Ziegler, O, Scherbaum, Wa, Jordan, J, Halmy, L, Ferrannini, E, Santini, F, Gonzalez, C, Narkiewicz, K, Hancu, N, Payer, J, Pascual, J, Wilding, J, Campbell, L, Carey, D, Gerstman, M, Karrasch, J, Lefkovits, J, Marks, J, Marks, S, Moses, R, Phillips, P, Proietto, J, Roberts, D, Roberts-Thomson, P, Shaw, J, Simpson, R, Singh, B, Singleton Jeffries, W, Stuckey, B, Boland, J, Brohet, C, Coucke, F, Dendale, P, Jouret, G, Kolanowski, J, Kutnowski, M, Martens, F, Muls, E, Peiffer, F, Penninckx, H, Scheen, A, Schoors, D, Vaerenberg, M, Van Cleemput, J, Van Crombrugge, P, Van Kuyk, M, Verhaegen, A, Wollaert, B, de Albuquerque DC, Appolinario, J, de Godoy Matos AF, Gross, Jl, Halpern, A, Kerr Saraiva JF, Milagres, R, Repetto, G, Suplicy, Hl, Zanella, Mt, Bednarova, J, Cepelak, V, Cerny, P, Hainer, V, Havranek, P, Homza, M, Jansa, P, Karlicek, M, Kolesar, J, Kotik, I, Kucera, D, Kuchar, J, Kunc, M, Kvapil, M, Linhart, A, Machova, V, Matuska, J, Oral, I, Pavlas, J, Pesatova, S, Povolny, J, Semrad, B, Smetana, K, Soucek, M, Svacina, S, Tesinsky, P, Urbanek, R, Wasserburger, B, Zachoval, R, Zahumensky, E, Zidkova, E, Astrup, A, Dominguez, H, Faber, J, Hilderbrant, P, Kober, L, Perrild, H, Richelsen, B, Sogaard, P, Svendsen, Ol, Urhammer, S, Archambeaud, F, Basdevant, A, Borys, Jm, Bringer, J, Brunetiere, C, Charpentier, G, Cocaul-André, M, Dabadie, H, Dubreuil, A, Estour, B, Gautier, Jf, Gibault, T, Halimi, S, Hespel, Jp, Issa Sayegh, M, Krempf, M, Laville, M, Lecerf, Jm, Louvet, Jp, Penfornis, A, Ritz, P, Schlienger, Jl, Schmitt, B, Valensi, P, Baar, M, Beermann, J, Bock, M, Boenner, G, Dammann, Hg, Diehm, C, Ditschuneit, H, Gadow, J, Gehlhar, S, Gessner, S, Guthersohn, A, Hamann, A, Hanefeld, M, Hasenfuss, G, Herzner, A, Heun, Kc, Heufelder, Ae, Hohensee, H, Jacob, S, Krings, P, Krätzig, B, Krosse, B, Lehmann, Rt, Mindt-Prüfert, S, Maisch, B, Pfeiffer, Af, Richard, F, Rose, B, Schmidt, E, Scholze, J, Schreckenberg, A, Stuebler, P, Walter, J, Wirth, A, Wunderlich, J, Abraham, G, Altorjay, A, Augusztin, G, Csaszar, A, Czuriga, I, Dinnyes, J, Gero, L, Gyimesi, A, Janosi, A, Kovacs, I, Liziczai, I, Majtenyi, A, Medvegy, M, Nadhazi, Z, Pados, G, Polak, G, Ronaszeki, A, Sido, Z, Simon, K, Anzà, C, Bevilacqua, M, Bosello, O, Chiariello, M, Cordera, R, Ferrari, E, Frittitta, L, Giorgino, R, Liuzzi, A, Malinverni, C, Di Mario, U, Melchionda, N, Occhi, G, Perticone, F, Pinchera, A, Pinelli, G, Rovera, G, Santeusanio, F, Urbinati, S, Alpizar-Salazar, M, Carrillo-Ortega, E, Fanghanel Salmon, G, Laviada-Molina, Ha, Madero, Ma, Rodriguez, G, Saldate, C, Sanchez-Castillo, Cp, Violante, Rm, Wacher, N, Zayas-Jaime, Fj, Zuniga-Guajardo, S, Adamiec, R, Banasiak, W, Chrusciel, P, Derlaga, B, Gebala, A, Gessek, J, Janik, K, Janion, M, Kalina, Z, Kozlowski, A, Kusnierz, B, Majcher, Z, Miekus, P, Niegowska, J, Okopien, B, Ostrowska, L, Pasowicz, M, Piepiorka, M, Pluta, W, Polaszewska-Muszynska, M, Ponikowski, P, Pupek-Musialik, D, Sawicki, A, Sobocik, H, Stankiewicz, A, Szpajer, M, Trojnar, R, Tykarski, A, Wrabec, K, Wyrzkowski, B, Zahorska-Markiewicz, B, Zalewski, M, Carrageta, M, Mendes Pedro MM, Parente Martins LM, dos Santos, L, Babes, A, Creteanu, G, Dan, Ga, Dragulescu, Si, Graur, M, Tirgoviste, Ci, Morosanu, M, Mota, M, Paveliu, Fs, Radoi, M, Ranetti, A, Totoian, I, Andre, I, Bugan, V, Cencarik, J, Csala, L, Farsky, S, Gonsorcik, J, Kamensky, G, Kmec, J, Krahulec, B, Kurian, R, Macek, V, Majercak, I, Micko, K, Mokan, M, Riecansky, I, Sojka, G, Uhliar, R, Urgeova, L, Vancik, J, Baro, Fm, Barrios Merino, A, Borras, Jl, Caixas, A, Cuatrecasas Cambra, G, Dominguez Escribano JR, Duran Garcia, S, Escobar-Jimenez, L, Esteva de Antonio, I, Formiguera Sala, X, Garcia-Luna, Pp, Garcia Robles, R, Gonzalez Albarran, O, Hernandez-Mijares, A, Martin Hidalgo, A, Masmiquel Comas, L, Morales Perez, F, Moreno Esteban, B, Pascual Izuel JM, Redon Mas, J, Ricart, W, Rubio, Ma, Ruilope, Lm, Salas-Salvado, J, Terroba Larumbe, M, Tinahones, F, de la Torre Casares ML, Vidal Cortada, J, Zuniga-Perez Lemaur, M, Abdulhakim, Ee, Adler, A, Barnett, Ah, Bodmer, C, Campbell, Iw, Chowdhury, T, Cleland, J, Cook, Rc, Dinneen, S, Donnachie, H, Haslam, Dw, Hillis, Gs, Horne, M, Howarth, Dj, Hughes, E, Jackson, S, Jones, Sc, Jones, Th, Kumar, S, Lean, M, Maroni, J, Mcinnes, G, Middleton, A, Morris, A, Newcombe, G, O'Kane, Kp, Pavel, Ic, Pawa, R, Perry, C, Pitts, C, Raja, A, Reckless, J, Robinson, J, Sarmiento, R, Soo, Sc, Taylor, S, Thomas, Ho, Thomson, Ma, and Wilkins, M.
- Subjects
Male ,medicine.medical_specialty ,Myocardial Infarction ,Blood Pressure ,Kaplan-Meier Estimate ,Type 2 diabetes ,Klinikai orvostudományok ,Placebo ,law.invention ,Double-Blind Method ,Randomized controlled trial ,Weight loss ,law ,Internal medicine ,Appetite Depressants ,medicine ,Humans ,Obesity ,Myocardial infarction ,Stroke ,Aged ,business.industry ,Hazard ratio ,Orvostudományok ,General Medicine ,Middle Aged ,Overweight ,medicine.disease ,Surgery ,Diabetes Mellitus, Type 2 ,Cardiovascular Diseases ,Cardiology ,Female ,Human medicine ,medicine.symptom ,business ,Cyclobutanes ,Sibutramine ,medicine.drug - Abstract
Background The long-term effects of sibutramine treatment on the rates of cardiovascular events and cardiovascular death among subjects at high cardiovascular risk have not been established. Methods We enrolled in our study 10,744 overweight or obese subjects, 55 years of age or older, with preexisting cardiovascular disease, type 2 diabetes mellitus, or both to assess the cardiovascular consequences of weight management with and without sibutramine in subjects at high risk for cardiovascular events. All the subjects received sibutramine in addition to participating in a weight-management program during a 6-week, single-blind, lead-in period, after which 9804 subjects underwent random assignment in a double-blind fashion to sibutramine (4906 subjects) or placebo (4898 subjects). The primary end point was the time from randomization to the first occurrence of a primary outcome event (nonfatal myocardial infarction, nonfatal stroke, resuscitation after cardiac arrest, or cardiovascular death). Results The mean duration of treatment was 3.4 years. The mean weight loss during the lead-in period was 2.6 kg; after randomization, the subjects in the sibutramine group achieved and maintained further weight reduction (mean, 1.7 kg). The mean blood pressure decreased in both groups, with greater reductions in the placebo group than in the sibutramine group (mean difference, 1.2/1.4 mm Hg). The risk of a primary outcome event was 11.4% in the sibutramine group as compared with 10.0% in the placebo group (hazard ratio, 1.16; 95% confidence interval [CI], 1.03 to 1.31; P=0.02). The rates of nonfatal myocardial infarction and nonfatal stroke were 4.1% and 2.6% in the sibutramine group and 3.2% and 1.9% in the placebo group, respectively (hazard ratio for nonfatal myocardial infarction, 1.28; 95% CI, 1.04 to 1.57; P=0.02; hazard ratio for nonfatal stroke, 1.36; 95% CI, 1.04 to 1.77; P=0.03). The rates of cardiovascular death and death from any cause were not increased. Conclusions Subjects with preexisting cardiovascular conditions who were receiving long-term sibutramine treatment had an increased risk of nonfatal myocardial infarction and nonfatal stroke but not of cardiovascular death or death from any cause. (Funded by Abbott; ClinicalTrials.gov number, NCT00234832.)
- Published
- 2010
- Full Text
- View/download PDF
6. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- Author
-
Agnelli, G, Berkowitz, S, Bounameaux, H, Büller, Hr, Cohen, A, Gallus, A, Lensing, Aw, Misselwitz, F, Haskell, L, Prins, Mh, Raskob, G, Schellong, S, Bauersachs, R, van Bellen, B, Boda, Z, Borris, L, Brenner, B, Brighton, T, Chlumsky, J, Davidson, B, Decousus, H, Eriksson, H, Jacobson, B, Kakkar, A, Kwong, Yl, Lee, Lh, Meijer, K, van der Meer, J, Minar, E, Monreal, M, Piovella, F, Sandset, Pm, Smith, M, Tomkowski, W, Verhamme, P, Wang, Y, Wells, P, Brandjes, D, Mac Gillavry, M, Otten, Hm, Carlsson, A, Laporte, S, Schulman, S, Gent, M, Turpie, A, Martinelli, I, Segers, A, Muhlhofer, E, Tewes, M, Trajanovic, M, Muller, K, Kim, C, Gebel, M, Benson, A, Pap, Af, Godrie, J, Horvat Broecker, A, Spadari, G, Peters Wulf, C, Roig, J, Baker, R, Bianchi, A, Blombery, P, Campbell, P, Carroll, P, Geraghty, R, Chong, B, Ramanathan, S, Archis, C, Coughlin, P, Salem, H, Crispin, P, Dean, M, Soni, R, Denaro, C, Kubler, P, Coghlan, D, Gan, Te, Tran, H, Coleman, C, Jackson, D, Khalafallah, A, Leahy, M, Leyden, M, Leyden, D, Sturtz, C, Mccann, A, Gibbs, H, Mcrae, S, Richards, B, Ward, C, Curnow, J, Baghestanian, M, Erdogmus, B, Samaha, E, Nikoupayan Mofrad, M, Hirschl, M, Sturm, W, Kirchmair, R, Marschang, P, Drexel, H, Mathies, R, Pilger, E, Brodmann, M, Weltermann, A, Buche, M, Demelenne, J, Gustin, M, Hainaut, P, Pothen, L, de Leersnyder, J, Motte, S, Schroë, H, Sprynger, M, Peerlinck, K, Delcroix, M, Vermassen, F, Verstraeten, P, Smet, V, Vossaert, R, Panico, M, Costa, C, Blondal, J, Kovacs, M, Rodger, M, Carrier, M, Wong, T, Bi, J, Chen, Z, Chen, R, Jing, Zc, He, J, Liu, C, Liu, S, Long, S, Ma, Y, Shao, Y, Wang, C, Yang, Yh, Xie, C, Xu, J, Ying, K, Zhihong, L, Hola, D, Jirat, S, Vitovec, M, Kovářová, K, Gilík, J, Dosál, J, Mandakova, E, Matoška, P, Podpera, I, Podperova, M, Spacek, R, Urbanova, R, Tuxen, C, Sukles, K, Pietila, K, Vesanen, M, Achkar, A, Agraou, B, Aquilanti, S, Rifaï, A, Berremili, T, Brisot, D, Brousse, C, Tarodo, P, Bura, A, Amid Lacombe, C, Malloizel, J, Boulon, C, Alavoine, L, Crestani, B, Mismetti, P, Buchmuller, A, Accassat, S, Elias, A, Elias, M, Emmerich, J, Ferrari, E, Guérin, T, Beaka, P, Lacroix, P, Szwebel, Ta, Benhamou, Y, de Maistre, E, Falvo, N, Mahe, I, Meneveau, N, Schiele, F, Meyer, G, Sanchez, O, Planquette, B, Mottier, D, Le Moigne, E, Couturaud, F, Parent, F, Pernod, G, Imbert, B, Elkouri, D, Dary, M, Queguiner, A, Quere, I, Galanaud, Jp, Roy, Pm, de Boisjolly Bonnefoi JM, Schmidt, J, Breuil, N, Heuser, S, Sevestre, Ma, Simoneau, G, Bergmann, Jf, Stephan, D, Trinh Duc, A, Gaillardou, A, Grange, C, Fassier, T, Wahl, D, Baron Von Bilderling, P, Kuhlencordt, P, Beyer Westendorf, J, Halbritter, K, Werth, S, Diehm, C, Lawall, H, Eifrig, B, Espinola Klein, C, Weisser, G, Giannitsis, E, Haering, Hu, Hasslacher, C, Herrmann, T, Hoffmann, U, Czihal, M, Horacek, T, Ibe, M, Bauer, A, Kieback, A, Landgraf, H, Lindhoff Last, E, Malyar, N, Petermann, W, Potratz, J, Ranft, J, Röcken, M, Pomper, L, Frommhold, R, Schwaiblmair, M, Berghaus, T, Taute, B, Lau, Yk, Tse, E, Olah, Z, Farkas, K, Kolossváry, E, Gurzó, M, Kis, E, Kovács, A, Landi, A, Lupkovics, G, Pecsvarady, Z, Riba, M, Sipos, G, Parakh, R, Sembiring, R, Barton, J, Goldstein, L, Gavish, D, Hoffman, R, Hussein, O, Inbal, A, Lishner, M, Elis, A, Lugassy, G, Varon, D, Zeltser, D, Rogowski, O, Steinvil, A, Zisman, D, Ageno, W, Ambrosio, G, Cattaneo, M, D'Angelo, A, Ghirarduzzi, A, Lotti, M, Pierfranceschi, Mg, Lodigiani, C, Palareti, G, Barone, M, Beltrametti, C, Porreca, E, Prandoni, Paolo, Spiezia, L, Quintavalla, R, Cho, Wh, Ha, Jw, Kim, Hs, Park, K, Sime, I, Miliauskas, S, Petrauskiene, R, Sathar, J, Beeker, A, Ten Cate, H, De Groot, M, Kamphuisen, P, Douma, R, Kooy, Mv, Coenen, J, Mäkelburg, A, Knol, M, Tichelaar, V, Harper, P, Knottenbelt, E, Ockelford, P, Young, L, Royle, G, Simpson, D, Chunilal, S, Ghanima, W, Foyn, S, Tveit, A, Abola, Mt, Adamiec, R, Gorski, P, Kloczko, J, Lewczuk, J, Nowak, M, Musial, J, Wronski, J, Ng, Hj, Adler, D, Becker, Jh, Ellis, G, Isaacs, R, Bloy, B, Allie, R, Eckstein, F, van Rensburg JH, Schmidt, S, Siebert, H, Zyl, L, Carrera, M, Del Campo, F, Diego, I, Garcia Bragado, F, Jiménez, D, Sánchez Álvarez, J, Redondo, M, Roman Sanchez, P, Villalta, J, Villegas Scivetti, M, Jonson, T, Tygesen, H, Lapidus, L, Ottosson, E, Själander, A, Asmis, L, Banyai, M, Heidemann, M, Baumgartner, I, Righini, M, Frank, U, Hayoz, D, Periard, D, Chang, Wt, Chiu, K, Wang, Ky, Weng, Zc, Angchaisuksiri, P, Pothirat, C, Rojnuckarin, P, Solis, J, Hunt, B, Luckit, J, Albrecht, C, Banish, D, Feinbloom, D, Botnick, W, Chen, D, Dexter, J, Ettinger, N, Gleeson, J, Jaffer, A, Joseph, S, Kennedy, M, Krell, K, Lavender, R, Lyons, R, Moll, S, Nadar, V, Darrow, K, Hardman, V, Rathbun, S, Rehm, J, Rodriguez Cintron, W, Stevens, K, Wright, P, Ramaswamy, M., ACS - Amsterdam Cardiovascular Sciences, Vascular Medicine, Other departments, Epidemiologie, MUMC+: KIO Kemta (9), RS: CAPHRI School for Public Health and Primary Care, Department of Vascular Medicine (DVM - AMC), Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA)-University of Amsterdam [Amsterdam] (UvA), Department of Epidemiology (MHP), Maastricht University [Maastricht], Groupe de recherche sur la thrombose (GRT (EA 3065)), Université Jean Monnet [Saint-Étienne] (UJM), Service d'angiologie et d'hémostase (MR), Hôpital Universitaire de Genève, Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Centre d'Investigation Clinique (CIC - Brest), and Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
MESH: Pulmonary Embolism ,Male ,Vitamin K ,Administration, Oral ,Pulmonary Embolism/drug therapy/mortality ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,chemistry.chemical_compound ,0302 clinical medicine ,Rivaroxaban ,Edoxaban ,Recurrence ,Hemorrhage/chemically induced ,030212 general & internal medicine ,Vitamin K/antagonists & inhibitors ,Enoxaparin/adverse effects/therapeutic use ,MESH: Treatment Outcome ,MESH: Aged ,ddc:616 ,MESH: Middle Aged ,Hazard ratio ,General Medicine ,MESH: Follow-Up Studies ,Vitamin K antagonist ,MESH: Thiophenes ,Middle Aged ,Thrombosis ,Morpholines/adverse effects/therapeutic use ,3. Good health ,Pulmonary embolism ,MESH: International Normalized Ratio ,Treatment Outcome ,Anesthesia ,MESH: Administration, Oral ,Administration ,Combination ,Apixaban ,Drug Therapy, Combination ,Female ,MESH: Hemorrhage ,medicine.drug ,Oral ,MESH: Enoxaparin ,medicine.drug_class ,Morpholines ,Anticoagulants/adverse effects/therapeutic use ,MESH: Morpholines ,Hemorrhage ,Thiophenes ,MESH: Anticoagulants ,03 medical and health sciences ,Drug Therapy ,medicine ,Humans ,International Normalized Ratio ,Enoxaparin ,MESH: Kaplan-Meier Estimate ,Aged ,MESH: Humans ,business.industry ,MESH: Vitamin K ,Anticoagulants ,medicine.disease ,MESH: Male ,MESH: Recurrence ,Regimen ,MESH: Drug Therapy, Combination ,chemistry ,Thiophenes/adverse effects/therapeutic use ,business ,Pulmonary Embolism ,MESH: Female ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Follow-Up Studies - Abstract
International audience; BACKGROUND: A fixed-dose regimen of rivaroxaban, an oral factor Xa inhibitor, has been shown to be as effective as standard anticoagulant therapy for the treatment of deep-vein thrombosis, without the need for laboratory monitoring. This approach may also simplify the treatment of pulmonary embolism. METHODS: In a randomized, open-label, event-driven, noninferiority trial involving 4832 patients who had acute symptomatic pulmonary embolism with or without deep-vein thrombosis, we compared rivaroxaban (15 mg twice daily for 3 weeks, followed by 20 mg once daily) with standard therapy with enoxaparin followed by an adjusted-dose vitamin K antagonist for 3, 6, or 12 months. The primary efficacy outcome was symptomatic recurrent venous thromboembolism. The principal safety outcome was major or clinically relevant nonmajor bleeding. RESULTS: Rivaroxaban was noninferior to standard therapy (noninferiority margin, 2.0; P=0.003) for the primary efficacy outcome, with 50 events in the rivaroxaban group (2.1%) versus 44 events in the standard-therapy group (1.8%) (hazard ratio, 1.12; 95% confidence interval [CI], 0.75 to 1.68). The principal safety outcome occurred in 10.3% of patients in the rivaroxaban group and 11.4% of those in the standard-therapy group (hazard ratio, 0.90; 95% CI, 0.76 to 1.07; P=0.23). Major bleeding was observed in 26 patients (1.1%) in the rivaroxaban group and 52 patients (2.2%) in the standard-therapy group (hazard ratio, 0.49; 95% CI, 0.31 to 0.79; P=0.003). Rates of other adverse events were similar in the two groups. CONCLUSIONS: A fixed-dose regimen of rivaroxaban alone was noninferior to standard therapy for the initial and long-term treatment of pulmonary embolism and had a potentially improved benefit-risk profile. (Funded by Bayer HealthCare and Janssen Pharmaceuticals; EINSTEIN-PE ClinicalTrials.gov number, NCT00439777.).
- Published
- 2012
- Full Text
- View/download PDF
7. Macronutrient and Micronutrient Intake of Children in Oklahoma Child Care Centers
- Author
-
Rasbold, A.H., primary, Sisson, S.B., additional, Adamiec, R., additional, Horm, D.M., additional, Campbell, J.E., additional, Anderson, M.P., additional, and Sitton, L.K., additional
- Published
- 2015
- Full Text
- View/download PDF
8. FP20-TU-03 Evaluation of peripheral nervous system in patients with primary Raynaud's syndrome and dysautonomia
- Author
-
Koszewicz, M., primary, Gosk-Bierska, I., additional, Bilinska, M., additional, Budrewicz, S., additional, Podemski, R., additional, Slotwinski, K., additional, and Adamiec, R., additional
- Published
- 2009
- Full Text
- View/download PDF
9. Does smoking change clinical picture of atherosclerosis in type 2 diabetes mellitus?
- Author
-
Gosk-Bierska, I., primary, Adamiec, R., additional, and Wysokinski, W.E., additional
- Published
- 1999
- Full Text
- View/download PDF
10. The effect of smoking on progression and clinical characteristics of atherosclerosis in hypertensive patients
- Author
-
Wysokinski, W.E., primary, Adamiec, R., additional, and Gosk-Bierska, I., additional
- Published
- 1999
- Full Text
- View/download PDF
11. Interaction of the Pisum sativum nuclear matrix proteins with SAR DNA.
- Author
-
Rzepecki, R, primary, Markiewicz, E, additional, Adamiec, R, additional, and Szopa, J, additional
- Published
- 1995
- Full Text
- View/download PDF
12. Is an increase of deoxyribonucleases activity in uraemic lymphocytes caused by their augmented synthesis in these cells?
- Author
-
Adamiec, R., primary, Szewczyk, Z., additional, Szmidziński, R., additional, and Szopa, J., additional
- Published
- 1993
- Full Text
- View/download PDF
13. Is the 65 kDa protein a direct signal for the nuclease release from nuclear matrix, starting the apoptotic cascade?
- Author
-
Szopa, J, primary and Adamiec, R, additional
- Published
- 1993
- Full Text
- View/download PDF
14. Expression of extracellular calcium-sensing receptor in peripheral blood monocytes in patients with arteriosclerosis obliterans, diabetes mellitus type 2 complicated with macroangiopathy in the context of the selected proinflammatory factors.
- Author
-
Malecki R, Adamiec R, and Jakobsche U
- Published
- 2007
15. Antiatherogenic activity of antibodies against ox-LDL?
- Author
-
Sapian-Raczkowska B, Gacka M, and Adamiec R
- Published
- 2006
16. Increase in deoxyribonuclease activity in uraemic lymphocytes is caused by the cleavage of the largest polymerase I subunit.
- Author
-
Adamiec, R., Szewczyk, Z., Sikorski, A.F., and Szopa, J.
- Abstract
Deoxyribonucleases and DNA-dependent RNA polymerase activities in T and B lymphocytes isolated from patients with chronic renal failure and control subjects were studied. The data clearly shows that the nuclease activity in T and B cells isolated from uraemic patients is remarkably enhanced when compared to the control cells. Concomitant with the enhancement in enzyme activity, the reduction in RNA polymerase I activity and quantity was observed. It was found that the increase in nuclease activity and quantity was limited to the group of relatively small nucleases with molecular weights ranging from 14kDa to 18kDa. It has been reported previously that these nucleases are among the cleavage products of the largest subunit of DNA-dependent RNA polymerase I. Thus we suggest that the depressed metabolic activity is a characteristic feature of the uraemic lymphocyte cells and the observed increased in DNase activity in those cells is a result of polymerase I degradation. [ABSTRACT FROM PUBLISHER]
- Published
- 1993
17. ROLE OF ANTI-HSP 60/65 ANTIBODIES IN ATHEROGENESIS IN PATIENTS WITH TYPE 2 DIABETES AND LOWER LIMB ISCHEMIA
- Author
-
Rabczynski, M., Fiodorenko-Dumas, Z., Adamiec, R., Małgorzata Paprocka-Borowicz, and Dumas, I.
18. [Richter's syndrome and cervical cancer in the course of a rheumatoid arthritis]
- Author
-
Kazimierz Kuliczkowski, Kaiser A, and Adamiec R
- Subjects
Arthritis, Rheumatoid ,B-Lymphocytes ,T-Lymphocytes ,Carcinoma ,Humans ,Uterine Cervical Neoplasms ,Female ,Lymph Nodes ,Lymphoma, Large B-Cell, Diffuse ,Syndrome ,Autoimmune Diseases ,Leukemia, Lymphoid - Abstract
The authors describe a rare case of Richter's syndrome (transition of chronic lymphatic leukaemia into reticulosarcoma) developing during rheumatoid arthritis in a women aged 53 years. Chronic antigenic stimulation and disturbances of interaction between lymphocytes T and B are suggested as a cause of Richter's syndrome.
19. Stężenie adrenomeduliny i endoteliny 1 w surowicy chorych na miażdżycę zarostową tętnic kończyn dolnych -- wpływ wysiłku fizycznego.
- Author
-
Knapik-Kordecka, M., Zdrojowy, K., and Adamiec, R.
- Abstract
Copyright of Acta Angiologica is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2006
20. Safety, professionalism, and the Marine ethos: 2003 Chase Prize Essay Contest: Honorable mention
- Author
-
Adamiec, Raymond, Col
- Subjects
PROFESSIONALISM ,MARINE CORPS - United States - Training ,RISK - Study and Teaching ,SAFETY PROGRAMS - Marine Corps ,OCCUPATIONAL SAFETY AND HEALTH - Published
- 2004
21. Susceptibility to apoptosis of lymphocytes from patients with peripheral arterial disease.
- Author
-
Skórkowska-Telichowska K, Adamiec R, Tuchendler D, Gasiorowski K, Skórkowska-Telichowska, Katarzyna, Adamiec, Rajmund, Tuchendler, Dominika, and Gasiorowski, Kazimierz
- Abstract
Purpose: To determine, in vitro, the susceptibility to apoptosis of lymphocytes from patients with peripheral arterial disease (PAD) in the presence of a low culture medium serum concentration, and to evaluate the correlation of the degree of apoptosis and the serum lipid levels.Methods: Lymphocytes were isolated from the venous blood of PAD patients with lower limb ischemia secondary to obliterative atherosclerosis of Fountain stage IIb. None of the patients had received hypo-lipemic therapy. The lymphocytes were incubated for 48 hr in media containing reduced concentrations of fetal calf serum. The study group consisted of 10 patients (7 men and 3 women), with a mean age of 67.0 +/- 4.0 yr. The control group consisted of ten healthy volunteers, of the same mean age and sex proportion as the study group.Results: The percentage of non-apoptotic lymphocytes was lower (by 17%) and the percentage of late apoptotic lymphocytes was higher (by 33%) in the PAD patients than in the healthy donors when comparing the slopes of regression lines describing the relation between frequency of apoptotic lymphocytes in culture media containing reduced concentration of fetal calf serum The percentage of late apoptotic lymphocytes was correlated with the levels of total cholesterol (rs=0.93; P < 0.01) and LDL cholesterol (rs=0.80; P < 0.01) , and negatively correlated with the level of triglycerides (rs=-0.71; P < 0.05).Conclusion: The results of this study of lymphocyte apoptosis are important in understanding of the disease pathogenesis and should be taken into account in elaboration of treatment strategies. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
22. Hypothenar hammer syndrome wikłany krytycznym niedokrwieniem palców ręki u instruktora sportów walki -- opis przypadku.
- Author
-
Kluz, J., Małecki, R., and Adamiec, R.
- Abstract
Copyright of Acta Angiologica is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2006
23. Niedokrwienie kończyn dolnych u chorych z czerwienicą prawdziwą -- opis 2 przypadków.
- Author
-
Sapian-Raczkowska, B., Gosk-Bierska, I., Rabczyński, M., and Adamiec, R.
- Abstract
Copyright of Acta Angiologica is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2006
24. Niedobór białka C u 50-letniego chorego na zarostowo--zakrzepowe zapalenie naczyń.
- Author
-
Sapian-Raczkowska, B., Rabczyński, M., Małecki, R., and Adamiec, R.
- Abstract
Copyright of Acta Angiologica is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2006
25. Monocytarna ekspresja CD44 u chorych z przewlekłym niedokrwieniem kończyn dolnych i obecnymi markerami stanu zapalnego śródbłonka.
- Author
-
Protasiewicz, J., Dotyk, A., and Adamiec, R.
- Abstract
Copyright of Acta Angiologica is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2006
26. Ocena stężenia różnych postaci inhibitora szlaku czynnika tkankowego u chorych z przewlekłym niedokrwieniem kończyn w przebiegu procesu miażdżycowego.
- Author
-
Gosk-Bierska, I., Mc Bane, R., Karnicki, K., and Adamiec, R.
- Abstract
Copyright of Acta Angiologica is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2006
27. Proces apoptozy limfocytów krwi obwodowej w miażdżycy zarostowej (doniesienie wstępne).
- Author
-
Skórkowska-Telichowska, K., Gąsiorowski, K., and Adamiec, R.
- Abstract
Copyright of Acta Angiologica is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2006
28. Makroangiopatia cukrzycowa kończyn dolnych a ekspresja syntezy wybranych cytokin monocytów krwi obwodowej.
- Author
-
Gacka, M., Dobosz, T., Szymaniec, S., Bednarska-Chabowska, D., and Adamiec, R.
- Abstract
Copyright of Acta Angiologica is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2006
29. Zakrzepica zatok żylnych mózgu u chorego z izolowaną mutacją G20210A genu protrombiny.
- Author
-
Alexewicz, P., Gosk-Bierska, I., and Adamiec, R.
- Abstract
Copyright of Acta Angiologica is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2006
30. PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments.
- Author
-
Skoczyńska A, Ołdakowska M, Dobosz A, Adamiec R, Gritskevich S, Jonkisz A, Lebioda A, Adamiec-Mroczek J, Małodobra-Mazur M, and Dobosz T
- Subjects
- Animals, Humans, Biomedical Research history, History, 20th Century, Peroxisome Proliferator-Activated Receptors metabolism
- Abstract
This year marks the 35th anniversary of Professor Walter Wahli's discovery of the PPARs (Peroxisome Proliferator-Activated Receptors) family of nuclear hormone receptors. To mark the occasion, the editors of the scientific periodical Biomolecules decided to publish a special issue in his honor. This paper summarizes what is known about PPARs and shows how trends have changed and how research on PPARs has evolved. The article also highlights the importance of PPARs and what role they play in various diseases and ailments. The paper is in a mixed form; essentially it is a review article, but it has been enriched with the results of our experiments. The selection of works was subjective, as there are more than 200,000 publications in the PubMed database alone. First, all papers done on an animal model were discarded at the outset. What remained was still far too large to describe directly. Therefore, only papers that were outstanding, groundbreaking, or simply interesting were described and briefly commented on.
- Published
- 2024
- Full Text
- View/download PDF
31. The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors - a prospective study.
- Author
-
Tupikowski K, Jaobsche-Policht U, Bittner J, Ptaszkowski K, Halon A, Zdrojowy R, Adamiec R, and Gosk-Bierska I
- Abstract
Introduction: Multiple studies suggest that cancer leads to activation of clotting and fibrinolysis pathways, elevating the risk of thromboembolic events. Kidney cancer is often complicated by clotting disorders. In this study, we hypothesized that preoperative clotting and fibrinolysis parameters are altered in healthy volunteers and kidney tumor patients. We also hypothesized that these differences may be associated with survival in patients who have undergone operations due to kidney tumors., Material and Methods: In this study, 96 patients with kidney tumors and 30 healthy volunteers were recruited at a single university center. All patients were assessed for pre-operative serum concentrations of tissue factor (TF), tissue factor pathway inhibitor (TFPI, total TFPI, full-length TFPI, truncated TFPI), plasmin-antiplasmin complex (PAP), thrombin-antithrombin complex (TAT), von Willebrand factor (vWF), clotting factor XIII A1 (FXIIIA1), D-dimers, and fibrinogen. Additionally, standard peripheral blood morphology was evaluated., Results: Malignant kidney tumors were diagnosed in 85 of 96 tumor patients. In patients with kidney tumors, there were statistically significantly higher concentrations of fibrinogen, D-dimers, TAT, PAF, TF, TFPI, vWF, FXIIIA1, and leukocyte counts compared to the control group. Statistically significant correlations were found between multiple parameters. This points to significant clotting system alterations. Cox stepwise hazard analysis showed that pre-operative fibrinogen and D-Dimer concentrations were significantly associated with survival., Conclusions: In patients with kidney tumors, multiple clotting and fibrinolysis parameters are significantly altered. Routine pre-operative measures should include determination of fibrinogen and D-dimer concentrations as these markers aid in prediction of survival probability., Competing Interests: The authors declare no conflict of interest., (Copyright: © 2021 Termedia & Banach.)
- Published
- 2021
- Full Text
- View/download PDF
32. Lack of evidence of the correlation between plasma Asymmetrical Dimethylarginine correlation and IMT in type 2 diabetic patients with chronic vascular complication.
- Author
-
Fiodorenko-Dumas Z, Dumas I, Rabczynski M, Małecki R, Adamiec R, and Paprocka-Borowicz M
- Subjects
- Adult, Aged, Arginine blood, Atherosclerosis diagnostic imaging, Carotid Artery, Internal diagnostic imaging, Carotid Intima-Media Thickness, Case-Control Studies, Chronic Disease, Diabetic Angiopathies diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Factors, Ultrasonography, Doppler, Color methods, Arginine analogs & derivatives, Atherosclerosis complications, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 complications, Diabetic Angiopathies blood, Diabetic Angiopathies complications
- Abstract
Introduction: Patients with type 2 diabetes represent 50% of all sudden cardiac deaths. Disseminated arteriosclerotic lesions are the cause of vascular incidents that cause permanent disability resulting from lower limb amputations., Objectives: Our study was designed to investigate the relationship between asymmetrical dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) plasma concentration and intima-media thickness (IMT) in subjects with diabetes mellitus without vascular complications (group A) and a group of diabetic patients diagnosed with diabetes micro- and macroangiopathy (group B)., Patients and Method: The experimental groups included 42 diabetic patients. Group A - 22 patients (9 W and 13 M), free from vascular complications (mean age 55.83±7.37 years), group B - 20 patients (6 W, 14 M) with accompanying micro- and macropathic changes (mean age 63.80±8.79 years). Group C (n=22), the control group, consisted of healthy volunteers (12 W and 10 M), between the ages of 40 to 60 (mean age 51.16±6.39), selected in reference to the age and sex of the research group. The carotid artery intima-media complex thickness (IMT) was evaluated with the use of a duplex ultrasound., Conclusions: There was no correlation between ADMA and the maximal or mean intima-media thickness (IMT) of the common carotid artery (CCA) and internal carotid artery (ICA). We demonstrated a correlation between symmetric dimethylarginine (SDMA) concentration and CCA IMT. The results suggest that ICA IMT may serve as a marker of vascular complication among patients with diabetes.
- Published
- 2021
- Full Text
- View/download PDF
33. Advanced glycation end products derived from serum albumin modification by glucose (AGE-1) reflect clustering of lipid-associated metabolic abnormalities and are decreased in patients treated with acarbose: A cross-sectional study.
- Author
-
Bronowicka-Szydełko A, Krzystek-Korpacka M, Kuzan A, Gostomska-Pampuch K, Gacka M, Jakobsche-Policht U, Adamiec R, and Gamian A
- Subjects
- Cross-Sectional Studies, Glucose metabolism, Humans, Acarbose therapeutic use, Diabetes Mellitus blood, Glycation End Products, Advanced analysis, Prediabetic State blood, Serum Albumin analysis
- Abstract
Background: Advanced glycation end products (AGEs) are formed during protein modification by a reduction of sugars or reactive aldehydes. Depending on the pathology, various AGEs may be formed. They are stable compounds and are considered as potential diseases markers., Objectives: The objective of this study was to assess glucose-mediated albumin modification that yields non-standard epitopes of AGEs (AGE-1) in diabetes and in associated metabolic abnormalities., Material and Methods: The AGE-1, expressed as median AGE-1 level and AGE-1 positivity, was determined in 246 individuals (198 with prediabetes/diabetes) using a new slot-dot-blot method (allowing for detection of barely traceable analytes) and related to the presence of diabetes-associated metabolic abnormalities and complications, and treatment., Results: The AGE-1 level was higher in patients with prediabetes/diabetes than in controls. Its elevation was associated with metabolic syndrome (MetS), obesity, hyperlipidemia, and non-alcoholic fatty liver disease (NAFLD) but not with diabetic control or microand macroangiopathy, except for atherosclerotic plaques formation in carotid arteries. The AGE-1-positive patients had higher triglycerides and lower high-density lipoprotein (HDL)-cholesterol. In patients untreated with aspirin, AGE-1 positivity was associated with higher C-reactive protein (CRP) level. Treatment with aspirin, sulfonylureas and gliptins was associated with higher AGE-1 level and with dyslipidemia medications with higher AGE-1 positivity. In patients with abnormal glucose metabolism, acarbose treatment was associated with lower AGE-1 positivity. Multivariate analysis showed MetS, carotid artery plaques, NAFLD, and treatment with aspirin and acarbose to be independently associated with AGE-1 positivity., Conclusions: Unlike standard AGEs, AGE-1 is more tightly associated with abnormalities in lipid than glucose metabolism, and lower in patients treated with acarbose but not with other antidiabetics.
- Published
- 2020
- Full Text
- View/download PDF
34. Diabetic autonomic neuropathy of the gastrointestinal tract.
- Author
-
Kuźnik E, Dudkowiak R, Adamiec R, and Poniewierka E
- Abstract
Diabetes is a metabolic disease leading to the development of numerous health complications. In developed countries, it is the main cause of blindness, end-stage renal disease, and non-traumatic amputation of the lower limbs. Neuropathy is the most common chronic complication of diabetes. A long-term course of a metabolically unbalanced disease causing damage to the autonomic nervous system of the digestive tract results in the development of many complications, such as intensification of gastro-oesophageal reflux disease, gastroparesis, chronic diarrhoea or faecal incontinence., Competing Interests: The authors declare no conflict of interest., (Copyright: © 2020 Termedia Sp. z o. o.)
- Published
- 2020
- Full Text
- View/download PDF
35. Non-standard AGE4 epitopes that predict polyneuropathy independently of obesity can be detected by slot dot-blot immunoassay.
- Author
-
Bronowicka-Szydełko A, Krzystek-Korpacka M, Kuzan A, Gostomska-Pampuch K, Gacka M, Jakobsche-Policht U, Adamiec R, and Gamian A
- Subjects
- Biomarkers blood, Enzyme-Linked Immunosorbent Assay, Humans, Immunoassay, Epitopes, Glycation End Products, Advanced blood, Glycation End Products, Advanced genetics, Obesity genetics, Polyneuropathies genetics
- Abstract
Background: Advanced glycation end-products (AGEs) are formed during cascade reactions between reducing sugars or reactive aldehydes and proteins, lipids or DNA molecules. They constitute a group of various stable compounds. Advanced glycation end-products are considered potential biomarkers of metabolic disorders. However, so far only a few methods to determine the level of individual AGEs have been developed., Objectives: The aim of the study was to compare the efficiency of the slot-dot blot method and direct enzyme-linked immunosorbent assay (ELISA) in detecting non-standard epitopes of methylglyoxal (MGO)-modified proteins (AGE4) found in diabetes serum in trace amounts, and to assess AGE4 in diabetes and associated metabolic abnormalities., Material and Methods: The presence of AGE4 was detected using 2 methods: direct ELISA and the slot-dot blot method - a newly developed immunoassay based on monoclonal, commercially available antibody detection of non-standard AGE epitopes. AGE4 quantification, expressed as median AGE4 in arbitrary units (AU) and AGE4 positivity (the percent of samples with detectable AGE4) was related to diabetes-associated metabolic abnormalities, complications and treatment., Results: Slot-dot blot was significantly more efficient than ELISA in detecting non-standard AGE4 epitopes. AGE4 positivity was less frequent in patients with microangiopathy and in those with polyneuropathy. In patients with abnormal glucose metabolism, metformin treatment was associated with higher AGE4. AGE4 positivity was significantly lower in gliptin-treated patients. Multivariate analysis showed that polyneuropathy and obesity were independently associated with AGE4 positivity, with odds ratios (ORs) of 0.21 and 3.02, respectively. Moreover, logistic regression showed that AGE4 positivity and HbA1c are independent predictors of polyneuropathy. Considering both indicators allows correct classification of 70.4% of cases with a general accuracy of 76%., Conclusions: The slot dot-blot method detects compounds found in serum in trace amounts. Accumulation of AGE4 was associated with glucose metabolism abnormalities. A tendency toward AGE4 positivity was less frequent in patients with microangiopathy and in non-treated and gliptin-treated diabetes patients.
- Published
- 2020
- Full Text
- View/download PDF
36. Receptor GP IIb/IIIa as an Indicator of Risk in Vascular Events.
- Author
-
Fiodorenko-Dumas Ż, Dumas I, Mastej K, Jakobsche-Policht U, Bittner J, and Adamiec R
- Subjects
- Adult, Case-Control Studies, Diabetes Mellitus, Type 2 complications, Exercise physiology, Female, Fibrinogen metabolism, Humans, Male, Middle Aged, von Willebrand Factor metabolism, Cardiovascular Diseases etiology, Platelet Glycoprotein GPIIb-IIIa Complex metabolism, Risk Assessment
- Abstract
Type 2 diabetes causes a significant risk of cardiovascular diseases, leading to 70% of deaths in patients with diabetes. The effective treatment of diabetes significantly reduces the risk of requiring the involvement of specialists from various fields of medicine. This research aimed to assess the risk of cardiovascular events based on selected biochemical parameters (glycoprotein [GP] IIb/IIIa, von Willebrand factor [vWf], fibrinogen) and their changes in response to physical exercise. The research group consisted of 52 patients with type 2 diabetes with micro- or macro-angiopathy at a mean age of 63.80 years (8.79). The control group consisted of 50 healthy volunteers (17 women and 33 men) at a mean age of 51.16 years (6.39). All the patients consented to have their venous blood tested to measure complete blood counts. Activated GP IIb/IIIa receptors were labeled and analyzed by flow cytometry. Mean values of vWF factor were higher when compared with the control group (196.59% [80.32%] vs 148.06% [90.34%], respectively). The GP IIb/IIIa receptor expression was much higher in test patients than in the control group (3.91% [2.91%] vs 2.79% [2.51%]). Physical exercise had a positive influence on GP IIb/IIIa receptor expression and vWF, decreasing their baseline percentage values.
- Published
- 2019
- Full Text
- View/download PDF
37. Analysis of peripheral nerve and autonomic nervous system function and the stage of microangiopathy in patients with secondary Raynaud's phenomenon in the course of connective tissue diseases.
- Author
-
Gosk-Bierska I, Misterska-Skóra M, Wasilewska M, Bilińska M, Gosk J, Adamiec R, and Koszewicz M
- Subjects
- Case-Control Studies, Humans, Neural Conduction, Peroneal Nerve, Autonomic Nervous System physiology, Connective Tissue Diseases physiopathology, Peripheral Nerves physiology, Raynaud Disease physiopathology
- Abstract
Background: The pathogenesis of secondary Raynaud's phenomenon (SRP) associated with connective tissue diseases (CTD) is not entirely understood. Nervous system dysfunction and microangiopathy are considered to be causes of this pathology., Objectives: Peripheral and autonomic nervous system function, the stage of microangiopathy, and the relationships between these in patients with SRP were analyzed., Material and Methods: In the study, 20 patients with CTD-related SRP and 30 healthy controls were subject to capillaroscopy, standard conduction velocity tests and conduction velocity distribution (CVD) tests in ulnar and peroneal nerves, heart rate variability (HRV), and sympathetic skin response (SSR) tests., Results: There were no significant differences in the standard motor and sensory conduction velocity tests, or in CVD tests in the ulnar and peroneal nerves in SRP patients compared with the controls. The patients with SRP had a significantly lower SSR amplitude and longer latency in hands and feet. The patients with CTD-related SRP had a significantly lower mean HRV with higher low frequency (LF) values in the spectral analysis and expiration/inspiration ratio (E/I) during deep breathing. There was no correlation between the stage of microangiopathy and neurophysiological test results., Conclusions: Correct standard conduction velocity and CVD testing in patients with SPR suggest that vasomotor disturbances may occur in CTD regardless of peripheral neuropathy. The lack of relationship between SSR and microangiopathy could confirm that these 2 processes occur independently in patients with CTD-related SRP. Autonomic nervous system impairment together with normal peripheral nerve function suggest the central origin of CTD-related SRP.
- Published
- 2018
- Full Text
- View/download PDF
38. Peripheral circulatory disorders in essential thrombocythemia.
- Author
-
Małecki R, Gacka M, Fiodorenko-Dumas Ż, Dumas I, Kwiatkowski J, Adamiec R, and Kuliszkiewicz-Janus M
- Subjects
- Adult, Aged, Case-Control Studies, Cross-Sectional Studies, Female, Humans, Male, Manometry, Middle Aged, Peripheral Vascular Diseases diagnosis, Peripheral Vascular Diseases physiopathology, Photoplethysmography, Plethysmography, Impedance, Pulse Wave Analysis, Regional Blood Flow, Skin Temperature, Thermography, Thrombocythemia, Essential diagnosis, Vascular Resistance, Vascular Stiffness, Hemodynamics, Microcirculation, Peripheral Vascular Diseases etiology, Thrombocythemia, Essential complications, Upper Extremity blood supply
- Abstract
A significant number of patients with essential thrombocythemia (ET) complain of symptoms including distal parts of the extremities (e.g., paresthesias or Raynaud's phenomenon). The aim of the present study was to examine peripheral circulation in the upper extremities of individuals with ET. The study included 45 ET patients and 30 control subjects. All participants were subjected to thermography, photoplethysmography, impedance plethysmography, and applanation tonometry pulse wave analysis. The patients with ET differed significantly from the control subjects in terms of 3rd finger skin temperature (mean 31.04 vs. 32.45°C), skin temperature gradient (mean 1.82 vs. 0.11°C), photoplethysmographic amplitude (median 0.25 vs. 0.74%), and pulse waveform in the radial artery (more frequent occurrence of type B waveform). Pulse wave parameters correlated with the skin temperature gradient. The study findings imply the altered regulation of peripheral circulation in ET, including a decreased flow and an increased resistance., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
39. Physical activity - related changes in ADMA and vWF levels in patients with type 2 diabetes: A preliminary study.
- Author
-
Fiodorenko-Dumas Z, Dumas I, Mastej K, and Adamiec R
- Subjects
- Adult, Arginine blood, Cholesterol, HDL blood, Female, Humans, Male, Middle Aged, Arginine analogs & derivatives, Diabetes Mellitus, Type 2 blood, Exercise, von Willebrand Factor analysis
- Abstract
Background: The activity and the role of methylarginine in diabetic patients are subject to continuous research. The mechanism through which diabetes or insulin resistance increases asymmetric dimethylarginine (ADMA) serum levels is not fully understood. Studies indicate increased ADMA serum levels in patients with hypertension, hypercholesterolemia and hyperhomocysteinemia., Objectives: The aim of the study was to assess the changes in ADMA levels and its derivatives related to the current disease process, as well as the levels of selected prothrombotic factors and their changes induced by physical activity., Material and Methods: The study included 44 patients: group A (22 patients) - patients with diabetes with no vascular complications with mean age of 55.83 ± 7.37 years; and group B (22 patients) - healthy volunteers with the mean age of 51.16 ± 6.39 years. The authors' questionnaire was used to collect sociodemographic data in the study group. Physical exercise (Nordic walking) was practiced once per day for 30 min, 5 times a week. The assessment of peripheral blood parameters was performed using the ABX MICROS OT 16-parameter hematology analyzer. Additionally, chromatographic assay of serum levels of L-arginine, ADMA and symmetric dimethylarginine (SDMA) was performed., Results: There were statistically significant differences in ADMA levels in the respondents with type 2 diabetes vs healthy volunteers after training (0.763 ± 0.043 vs 0.532 ± 0.046; p = 0.001)., Conclusions: ADMA and SDMA levels in diabetic patients significantly exceeded standard values.
- Published
- 2017
- Full Text
- View/download PDF
40. Macronutrient and micronutrient intakes of children in Oklahoma child-care centres, USA.
- Author
-
Rasbold AH, Adamiec R, Anderson MP, Campbell JE, Horm DM, Sitton LK, and Sisson SB
- Subjects
- Child, Child, Preschool, Dietary Carbohydrates administration & dosage, Dietary Proteins administration & dosage, Energy Intake, Humans, Infant, Nutritional Status, Oklahoma, Recommended Dietary Allowances, Child Day Care Centers, Diet, Micronutrients administration & dosage
- Abstract
Objective: To determine macronutrients and micronutrients in foods served to and consumed by children at child-care centres in Oklahoma, USA and compare them with Dietary Reference Intakes (DRI)., Design: Observed lunch nutrients compared with one-third of the age-based DRI (for 1-3 years-olds and 4-8-year-olds). Settings Oklahoma child-care centres (n 25), USA., Subjects: Children aged 3-5 years (n 415)., Results: Regarding macronutrients, children were served 1782 (sd 686) kJ (426 (sd 164) kcal), 22·0 (sd 9·0) g protein, 51·5 (sd 20·4) g carbohydrate and 30·7 (sd 8·7) % total fat; they consumed 1305 (sd 669) kJ (312 (sd 160 kcal), 16·0 (sd 9·1) g protein, 37·6 (sd 18·5) g carbohydrate and 28·9 (sd 10·6) % total fat. For both age-based DRI: served energy (22-33 % of children), protein and carbohydrate exceeded; consumed energy (7-13 % of children) and protein exceeded, while carbohydrate was inadequate. Regarding micronutrients, for both age-based DRI: served Mg (65·9 (sd 24·7) mg), Zn (3·8 (sd 11·8) mg), vitamin A (249·9 (sd 228·3) μg) and folate (71·9 (sd 40·1) µg) exceeded; vitamin E (1·4 (sd 2·1) mg) was inadequate; served Fe (2·8 (sd 1·8) mg) exceeded only in 1-3-year-olds. Consumed folate (48·3 (sd 38·4) µg) met; Ca (259·4 (sd 146·2) mg) and Zn (2·3 (sd 3·0) mg) exceeded for 1-3-year-olds, but were inadequate for 4-8-year-olds. For both age-based DRI: consumed Fe (1·9 (sd 1·2) mg) and vitamin E (1·0 (sd 1·7) mg) were inadequate; Mg (47·2 (sd 21·8) mg) and vitamin A (155·0 (sd 126·5) µg) exceeded., Conclusions: Lunch at child-care centres was twice the age-based DRI for consumed protein, while energy and carbohydrate were inadequate. Areas of improvement for micronutrients pertain to Fe and vitamin E for all children; Ca, Zn, vitamin E and folate for older pre-schoolers. Adequate nutrients are essential for development and the study reveals where public health nutrition experts, policy makers and care providers should focus to improve the nutrient density of foods.
- Published
- 2016
- Full Text
- View/download PDF
41. Single nucleotide polymorphisms in 5'-UTR of the SLC2A4 gene regulate solute carrier family 2 member 4 gene expression in visceral adipose tissue.
- Author
-
Malodobra-Mazur M, Bednarska-Chabowska D, Olewinski R, Chmielecki Z, Adamiec R, and Dobosz T
- Subjects
- Diabetes Mellitus, Type 2 genetics, Humans, 5' Untranslated Regions, Glucose Transporter Type 4 genetics, Intra-Abdominal Fat metabolism, Polymorphism, Single Nucleotide
- Abstract
Background: The glucose uptake by numerous cells like adipocytes or skeletal muscle cells requires activation of specific proteins called glucose transporters. GLUT4 content and its activation as well as SLC2A4 gene expression level are decreased in patients with type 2 diabetes. The SLC2A4 gene expression rate might be modulated by genetic variances in UTRs. The relationship between two SNPs in 5'UTR and one SNP in 3'UTR and SLC2A4 gene expression rate in adipose tissue and lymphocytes has been evaluated., Methods: The study was performed on lymphocytes collected from 34 type 2 diabetic patients and equal number of controls. Visceral adipose tissue biopsies were collected from 15 patients with T2DM and from 24 controls., Results: SLC2A4 gene expression level was slightly lower within type 2 diabetic patients in both type of tissues. Furthermore, the negative correlation between SLC2A4 gene expression level in visceral adipose tissue and BMI has been noticed. The genotypes of two SNPs in 5'UTRs (rs5417 and rs5418) were correlated with lower mRNA amount of GLUT4 within recessive homozygotes belonging to control group., Conclusions: Present results suggest the relationship between genetic variances within UTRs of SLC2A4 gene and gene expression rate. However, the relationship is tissue specific and is noticeable in adipose tissue of lean and healthy subjects., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
42. Altered plasma fibrin clot properties in essential thrombocythemia.
- Author
-
Małecki R, Gacka M, Kuliszkiewicz-Janus M, Jakobsche-Policht U, Kwiatkowski J, Adamiec R, and Undas A
- Subjects
- Adult, Aged, Biomarkers blood, Blood Platelets pathology, C-Reactive Protein metabolism, Case-Control Studies, Female, Fibrin Clot Lysis Time, Humans, Janus Kinase 2 blood, Male, Middle Aged, Nephelometry and Turbidimetry, P-Selectin blood, Plasminogen Activator Inhibitor 1 blood, Platelet Activation, Platelet Count, Platelet Factor 4 blood, Thrombocythemia, Essential complications, Thrombocythemia, Essential pathology, Thrombosis complications, Thrombosis pathology, Tissue Plasminogen Activator blood, Blood Platelets metabolism, Fibrin metabolism, Fibrinogen metabolism, Thrombocythemia, Essential blood, Thrombosis blood
- Abstract
Patients with increased thromboembolic risk tend to form denser fibrin clots which are relatively resistant to lysis. We sought to investigate whether essential thrombocythemia (ET) is associated with altered fibrin clot properties in plasma. Ex vivo plasma fibrin clot permeability coefficient (Ks), turbidimetry and clot lysis time (CLT) were measured in 43 consecutive patients with ET (platelet count from 245 to 991 × 10(3)/µL) and 50 control subjects matched for age, sex and comorbidities. Fibrinolysis proteins and inhibitors together with platelet activation markers were determined. Reduced Ks (-38%, p < 0.0001) and prolonged CLT (+34%, p < 0.0001) were observed in ET. The differences remained significant after adjustment for fibrinogen and platelet count. ET was associated with a slightly shorter lag phase (-5%, p = 0.01) and higher maximum absorbency of the turbidimetric curve (+6%, p < 0.001). The ET patients had higher plasma P-selectin by 193% (p < 0.00001) and platelet factor 4 (PF4) by 173% (p < 0.00001), with higher P-selectin observed in 19 (44%) patients with JAK-2 gene V617F mutation. Higher t-PA (+20%, p < 0.001), 23% higher plasminogen activator inhibitor-1, PAI-1 (+23%, p < 0.01) and unaltered thrombin-activatable fibrinolysis inhibitor, plasminogen and α2-antiplasmin activity were found in the ET group. Ks inversely correlated with fibrinogen, PF4 and C-reactive protein. CLT positively correlated only with PAI-1. Patients with ET display prothrombotic plasma fibrin clot phenotype including impaired fibrinolysis, which represents a new prothrombotic mechanism in this disease.
- Published
- 2016
- Full Text
- View/download PDF
43. The Pathogenesis and Diagnosis of Thromboangiitis obliterans: Is It Still a Mystery?
- Author
-
Małecki R, Kluz J, Przeździecka-Dołyk J, and Adamiec R
- Subjects
- Adult, Aged, Diagnosis, Differential, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Prevalence, Prognosis, Risk Factors, Thromboangiitis Obliterans therapy, Thromboangiitis Obliterans diagnosis, Thromboangiitis Obliterans epidemiology
- Abstract
Thromboangiitis obliterans (TAO) is a rare disease of unknown etiology that results in the occlusion of limb arteries located distally to the elbow and knee. Despite the fact that more than one hundred years have passed since its first description, knowledge on the pathogenesis of TAO and precipitating factors is still limited. Due to a lack of decisive noninvasive diagnostic methods and geographical differences in the prevalence of this condition, data on TAO epidemiology also remains sparse. This review presents important evidence on the pathogenesis and the course of the condition, as well as diagnostic modalities, with a focus on differential diagnosis. Theories on the pathogenesis of TAO include the theory of an infectious disease, coagulation disorders and injury to vascular endothelium resulting in activation of the inflammatory response. Differential diagnosis should exclude thoracic outlet syndrome, blue toe syndrome, infectious endocarditis, popliteal entrapment syndrome, Takayasu disease, primary and secondary systemic vasculitis, antiphospholipid syndrome, infection with the anaerobic Clostridium sp. bacilli and some less common conditions.
- Published
- 2015
- Full Text
- View/download PDF
44. Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2.
- Author
-
Żurawska-Płaksej E, Ługowska A, Hetmańczyk K, Knapik-Kordecka M, Adamiec R, and Piwowar A
- Subjects
- Aged, Albuminuria blood, Biomarkers blood, Case-Control Studies, Chitinase-3-Like Protein 1, Diabetes Mellitus, Type 2 enzymology, Female, Humans, Male, Middle Aged, Adipokines blood, Diabetes Mellitus, Type 2 blood, Diabetic Nephropathies blood, Hexosaminidases blood, Lectins blood
- Abstract
Objectives: To investigate chitotriosidase (CHIT1) activity and chitinase-3-like protein 1 (YKL-40) concentration in plasma of type 2 diabetic patients and evaluate their relationship with kidney dysfunction., Materials and Methods: 94 diabetic subjects and 33 controls were enrolled in the study. Plasma CHIT1 activity and YKL-40 concentration were measured along with routine laboratory parameters., Results: Levels of CHIT1 and YKL-40 in plasma of type 2 diabetic patients increased progressively with the degree of albuminuria. CHIT1 discriminated normoalbuminuric subjects from those with abnormal albuminuria better than YKL-40., Conclusions: CHIT1represent a supportive biomarker connected with development of diabetic vascular complications, especially kidney dysfunction.
- Published
- 2015
- Full Text
- View/download PDF
45. A relationship between serological markers of chronic C. pneumoniae and CMV infection and hsp60 in patients with atherosclerotic carotid stenosis.
- Author
-
Rabczyński M, Fiodorenko-Dumas Ż, Mastej K, Dumas I, Adamiec R, and Paprocka-Borowicz M
- Subjects
- Atherosclerosis complications, Carotid Stenosis complications, Case-Control Studies, Humans, Atherosclerosis blood, Biomarkers blood, Carotid Stenosis blood, Chaperonin 60 blood, Chlamydia Infections complications, Chlamydophila pneumoniae isolation & purification, Cytomegalovirus isolation & purification, Cytomegalovirus Infections complications
- Abstract
Unlabelled: A number of epidemiological studies conducted over the last decade indicate a relationship between specific pathogen infections and the development of atherosclerosis, although no pathogenetic pathways connecting these two have been determined. Recent reports support the role of heat shock proteins (HSPs) in atherogenesis. The HSPs are also believed to be a link between the infection and the development of atherosclerotic lesions. THE AIMS OF STUDY: Immunohistochemical evaluation of carotid artery segments to show the relationship between the presence of heat shock proteins and the serum levels of anti-hsp60 antibodies. An attempt to demonstrate a relationship between an expression of chronic C. pneumoniae and CMV antigens., Material and Methods: The study included 41 patients qualified for carotid artery endarterectomy and 18 healthy volunteers of corresponding age. Levels of anti- hsp60, anti-C. pneumoniae IgA and IgG, anti-CMV IgG antibodies as well as hsCRP were determined., Results: The mean serum levels of anti-hsp60 antibodies were higher in patients with advanced atherosclerosis as compared to healthy volunteers (55.3 ± 64.1 vs 32.8 ± 29.8; p < 0.05). There was a strong correlation between anti-hsp60 antibodies and the expression of hsp60 in carotid arterial wall, as confirmed by immunohistochemical evaluation. The study group showed statistically significant higher levels of hsCRP. Furthermore, statistically significant higher serum levels of anti-C. pneumoniae IgG and IgA as well as anti-CMV IgG antibodies were found in the study group as compared to controls. No correlation was shown between the markers of chronic infection induced by the tested pathogens and serum levels of anti-HSP and hsCRP., Conclusions: Higher protein expression in vascular walls is closely correlated with the level of anti-hsp60. At the same time, no significant relationship between anti-hsp60 antibodies and serological markers of infection was observed, which may only indicate an indirect role of infection in the assessment of breaking the immunological tolerance against autologous HSPs.
- Published
- 2015
- Full Text
- View/download PDF
46. Coexistence of Takayasus arteritis and ulcerative colitis.
- Author
-
Wasilewska M, Adamiec R, Hendrich B, and Gosk Bierska I
- Subjects
- Colitis, Ulcerative therapy, Humans, Male, Subclavian Artery diagnostic imaging, Takayasu Arteritis therapy, Tomography, X-Ray Computed, Young Adult, Colitis, Ulcerative complications, Colitis, Ulcerative diagnostic imaging, Takayasu Arteritis complications, Takayasu Arteritis diagnostic imaging
- Published
- 2015
- Full Text
- View/download PDF
47. Critical ischemia of the fingers in an auto mechanic as a result of occupational exposure.
- Author
-
Rabczyński M, Kuźnik E, Guziński M, and Adamiec R
- Subjects
- Adult, Humans, Maintenance, Male, Automobiles, Cumulative Trauma Disorders complications, Fingers blood supply, Ischemia etiology, Occupational Diseases complications
- Abstract
Hypothenar hammer syndrome is a rare cause of ischemic fingers observed mainly in young men smoking cigarettes and it is associated with repeated trauma of the ulnar artery in the area of the hypothenar eminence of the dominant-hand arm, resulting in a deficit of blood supply with the occurrence of hand symptoms typical for chronic and sometimes critical ischemia. Artery injury in this location is most often the result of multiple repetitions of the same activity being mostly the result of occupational exposure. We present a case of a 27-year-old car mechanic admitted to the hospital with symptoms of critical ischemia of the fingers III, IV, and V of the right hand, which resolved after conservative treatment., (This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.)
- Published
- 2015
- Full Text
- View/download PDF
48. Assessment of vascular function of hand allografts.
- Author
-
Małecki R, Gacka M, Boratyńska M, Dumas I, Jabłecki J, Chełmoński A, Fiodorenko-Dumas Z, Adamiec R, and Klinger M
- Subjects
- Adult, Composite Tissue Allografts diagnostic imaging, Female, Follow-Up Studies, Humans, Ischemia etiology, Male, Middle Aged, Outcome Assessment, Health Care, Plethysmography, Impedance, Ultrasonography, Doppler, Color, Composite Tissue Allografts blood supply, Hand Transplantation, Ischemia diagnosis, Postoperative Complications diagnosis
- Abstract
Background: Insufficiency of blood vessels supplying a limb allograft may lead to loss of the extremity. Thus, a regular evaluation of perfusion of transplants seems a reasonable approach. The purpose of the present study was assessment of allograft perfusion by means of non-invasive methods., Material/methods: Six hand allografts transplanted in 5 patients were included in the study group. The transplant procedure occurred on average 45 months before. The study group comprised 2 allografts at forearm level, 2 transplants of the arm, and 1 bilateral transplant of the forearm. Parameters of blood flow using Doppler ultrasonography, impedance plethysmography, Doppler measurement of segmental pressures, optical pulse oscillography (OPO), and thermography were performed in all participants., Results: DUS revealed increased resistive index in ulnar arteries of transplant hands compared to native hands and an altered blood supply was confirmed by IP. Flow-mediated dilatation within the transplanted extremity was abnormal in most patients and was inversely correlated with number of episodes of acute rejection. Analysis of oscillographic spectrum revealed flattening of the dicrotic notch in transplant hands. A tendency for lower temperature of the skin of transplanted hands compared to native extremities was also observed., Conclusions: In asymptomatic patients after limb transplantation, non-invasive methods disclosed discreet abnormalities of graft perfusion. Thus, regular measurement of perfusion parameters using these methods appears to be a promising approach to detect early and potentially reversible disturbances of blood supply. Further observational studies are required to determine its clinical significance.
- Published
- 2014
- Full Text
- View/download PDF
49. Impact of hormonal contraception on prothrombotic activity in vessels.
- Author
-
Gacka M and Adamiec R
- Subjects
- Administration, Cutaneous, Administration, Intravaginal, Administration, Oral, Animals, Contraceptive Agents, Female administration & dosage, Contraceptives, Oral administration & dosage, Contraceptives, Oral adverse effects, Humans, Intrauterine Devices, Medicated, Recurrence, Risk Assessment, Risk Factors, Venous Thromboembolism blood, Venous Thromboembolism epidemiology, Venous Thromboembolism prevention & control, Blood Coagulation drug effects, Contraceptive Agents, Female adverse effects, Venous Thromboembolism chemically induced
- Abstract
One of the most common, efficient and convenient methods of contraception is hormonal contraception. Due to its popularity among young women, the safety of this method should be taken into consideration. Alternative ways of hormonal application are used and additional prothrombotic factors are being researched in order to minimize prothrombotic activity. The paper presents current data on the relationship between hormonal contraception and vascular complications based on peer-reviewed medical journals that were published between the years 2001 and 2013.
- Published
- 2014
50. Etiological factors of infections in diabetic foot syndrome - attempt to define optimal empirical therapy.
- Author
-
Małecki R, Rosiński K, and Adamiec R
- Subjects
- Aged, Anti-Bacterial Agents therapeutic use, Bacterial Infections drug therapy, Drug Therapy, Combination, Female, Humans, Male, Bacterial Infections etiology, Diabetic Foot complications
- Abstract
Background: Diabetic foot syndrome (DFS) represents one of the most frequent reasons for lower limb amputation in developed countries. In most cases, it is associated with bacterial infection, requiring optimal antibiotic therapy., Objectives: The aim of this study was to identify the most frequent pathogens responsible for infections associated with DFS, establish the optimal protocol of empirical therapy, and ascertain the clinical variables that may determine the choice of the appropriate antibacterial agent., Material and Methods: The analysis included hospital records of patients treated at the Department between 2008 and 2010. A total of 102 individuals were identified; their material was cultured and tested for antibiotic susceptibility., Results: A total of 199 bacterial strains were isolated. There was a predominance of Gram-positive bacteria, particularly Staphylococcus aureus, Staphylococcus coagulase-negative strains, and Enterococcus faecalis. Of note was the high percentage of E. faecalis infection (16.08%). One can speculate on the potential etiological factors in the case of some bacteria, e.g. patients infected with S. aureus were characterized by higher monocytosis and lymphocytosis as compared to other patients. Analysis of drug susceptibility revealed that ciprofloxacin has the highest (but still only 44%) efficacy of all agents tested as monotherapy, and a combination of piperacillin and tazobactam or amoxicillin and clavulanate with aminoglycosides is particularly beneficial., Conclusions: Staphylococcus spp. predominates amongst the etiological factors of DFS infection; however, the rate of E. faecalis infection is alarmingly high. Monotherapy enables effective treatment in a minority of cases; therefore, at least two-drug protocols should be implemented from the very beginning of the therapy.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.